Market research
RMED Ra Medical Systems, Inc
NYSE MKT USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 7
- Dividend yield
- 0.0%
- Beta
- 0.18
Profile
Company facts
- Exchange
- NYSE MKT
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US74933X2036
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 7
- Dividend yield
- 0.0%
- Beta
- 0.18
About
About Ra Medical Systems, Inc
Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the RMED discussion.
5 years, 4 months ago
Ra Medical Systems, Inc is currently in a long term downtrend where the price is trading 27.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Ra Medical Systems, Inc's total revenue sank by 12.4% to $1M since the same quarter in the previous year.
Its net income has dropped by 7.2% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 2.1% to $-9M since the same quarter in the previous year.
Based on the above factors, Ra Medical Systems, Inc gets an overall score of 2/5.